At the end of one year, 42 patients on LAF237 plus metformin--a commonly prescribed drug--maintained an A1C level that was on average 1.1% lower than the 29 patients taking metformin and a placebo.

FORBES: Novartis Results Heat Up Diabetes Drug Race

The 11-plus exam is due to come to an end this year.

BBC: Derry school to ignore minister